Panagora Asset Management Inc Athira Pharma, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$2.26 - $4.22 $79,441 - $148,337	35,151 Added 30.93%	148,803 $372,000
Q4 2022 Feb 13, 2023	BUY	$2.76 - $3.71 $138,195 - $185,763	50,071 Added 78.75%	113,652 $360,000
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $47,427 - $64,100	16,187 Added 34.15%	63,581 $189,000
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $1,534 - $7,520	-560 Reduced 1.17%	47,394 $145,000
Q1 2022 May 12, 2022	BUY	$8.96 - $13.51 $429,667 - $647,858	47,954 New	47,954 $647,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.